Pilot Study of Pancreatic Cancer Screening | MicrobiomeTrials← Back to trialsNCT05058846
Pilot Study of Pancreatic Cancer Screening
TERMINATEDOBSERVATIONAL
Trial Details
Start: 2022-01-20Est. Completion: 2026-10-19
Enrollment target: 64 participants Locations- University of California San Francisco, San Francisco, California, United States
Other microbiome trials you might be interested in
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
This study investigates the first-line treatment of advanced pancreatic cancer with KRAS G12D mutation. Patients were ra…
Shanghai, ChinaEst. completion Apr 2029
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035